DSM to form global anti-infectives joint venture with Sinochem Group.

Royal DSM NV, the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that it has reached an agreement with Sinochem Group to form a 50/50 global joint venture for its business group DSM Anti-Infectives. The transaction is subject to receipt of regulatory approvals (including approvals from regulatory authorities in China) and customary clearances from competition authorities in the EU and elsewhere. In addition, DSM's works councils will be requested to render advice in relation to the proposed transaction.The parties anticipate closing to take place in 2Q 2011. Upon closing, the transaction will have retro-active effect to 1 Jan 2011. …